Platelet Activation in Chronic Inflammatory Skin Diseases

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2012 by Meir Medical Center.
Recruitment status was  Not yet recruiting
Information provided by (Responsible Party):
Meir Medical Center Identifier:
First received: December 28, 2012
Last updated: January 2, 2013
Last verified: December 2012
Platelets are blood cells that are important in coagulation of the blood. These cells have recently been shown to play a role in a number of other biologic processes, for example inflammation. In this study the investigators will determine the extent of platelet activation in people suffering from common chronic skin inflammation-urticaria and allergic dermatitis.

Condition Intervention
Atopic Dermatitis
Procedure: Blood sampling

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Meir Medical Center:

Primary Outcome Measures:
  • Platelet activation [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Platelet function will be assessed at enrollment

Secondary Outcome Measures:
  • Mean platelet volume [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Mean platelet volume will be assessed at enrollment

Estimated Enrollment: 80
Study Start Date: February 2013
Estimated Study Completion Date: October 2013
Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Skin disease
Patients with urticaria or atopic dermatitis
Procedure: Blood sampling
Blood sampling
Healthy volunteers
Procedure: Blood sampling
Blood sampling


Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Hospital clinic

Inclusion Criteria: Urticaria or atopic dermatitis -

Exclusion Criteria:Lack of informed consent

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01759693

Meir Medical Center Not yet recruiting
Kfar Saba, Israel, 44281
Contact: Martin H Ellis, MD    972-9-7471822   
Sub-Investigator: Martin H Ellis, MD         
Sponsors and Collaborators
Meir Medical Center
  More Information

Responsible Party: Meir Medical Center Identifier: NCT01759693     History of Changes
Other Study ID Numbers: 0113  MMC 0113 
Study First Received: December 28, 2012
Last Updated: January 2, 2013
Health Authority: Israel: Ethics Commission

Keywords provided by Meir Medical Center:
Platelet activation

Additional relevant MeSH terms:
Dermatitis, Atopic
Genetic Diseases, Inborn
Hypersensitivity, Immediate
Immune System Diseases
Skin Diseases
Skin Diseases, Eczematous
Skin Diseases, Genetic processed this record on April 27, 2016